/
Table  1. Cases of reported, confirmed cases of invasive pneumococcal disease: Table  1. Cases of reported, confirmed cases of invasive pneumococcal disease:

Table 1. Cases of reported, confirmed cases of invasive pneumococcal disease: - PowerPoint Presentation

myesha-ticknor
myesha-ticknor . @myesha-ticknor
Follow
343 views
Uploaded On 2019-06-22

Table 1. Cases of reported, confirmed cases of invasive pneumococcal disease: - PPT Presentation

number and rate per 100 000 population EU EEA 20102014 Source Country reports Legend Y yes N no C case based no report ASR agestandardised rate Suggested citation European Centre for Disease Prevention and Control Annual epidemiological report ID: 759633

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Table 1. Cases of reported, confirmed c..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Table 1. Cases of reported, confirmed cases of invasive pneumococcal disease: number and rate per 100 000 population, EU/EEA, 2010–2014

Source: Country reports. Legend: Y = yes, N = no, C = case based, · = no report, ASR: age-standardised rateSuggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive pneumococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Country

2010

2011

2012

2013

2014

Cases

Rate

Cases

Rate

Cases

Rate

Cases

Rate

National data

Report type

Reported cases

Confirmed cases

Rate

ASR

Austria

325

3.9

158

1.9

234

2.8

350

4.1

Y

C

322

322

3.8

3.5

Belgium

1851

-

1836

-

1738

-

1604

-

N

C

1192

1192

-

-

Bulgaria

26

0.4

37

0.5

19

0.3

17

0.2

Y

A

21

21

0.3

0.3

Croatia

.

.

.

.

18

0.4

16

0.4

Y

A

27

27

0.6

0.2

Cyprus

12

1.5

15

1.8

19

2.2

8

0.9

Y

C

14

14

1.6

1.7

Czech Republic

300

2.9

384

3.7

335

3.2

424

4.0

Y

C

337

337

3.2

3.1

Denmark

960

17.3

924

16.6

882

15.8

842

15.0

Y

C

725

725

12.9

12.1

Estonia

14

1.1

18

1.4

20

1.5

24

1.8

Y

C

12

12

0.9

0.9

Finland

834

15.6

779

14.5

752

13.9

724

13.3

Y

C

703

703

12.9

12.0

France

5117

10.5

5037

10.4

4430

9.0

3687

7.6

74%

C

3184

3184

6.5

6.2

Germany

.

.

.

.

.

.

.

.

.

.

.

.

.

.

Greece

38

0.3

41

0.4

43

0.4

40

0.4

Y

C

30

30

0.3

0.3

Hungary

108

1.1

107

1.1

186

1.9

202

2.0

Y

C

150

150

1.5

1.5

Iceland

32

10.1

33

10.4

27

8.4

19

5.9

Y

C

24

24

7.4

8.8

Ireland

304

6.7

357

7.8

350

7.6

347

7.6

Y

C

342

342

7.4

8.3

Italy

854

1.4

713

1.2

814

1.4

977

1.6

Y

C

957

957

1.6

1.4

Latvia

16

0.8

51

2.5

56

2.7

56

2.8

Y

C

51

51

2.5

2.4

Liechtenstein

.

.

.

.

.

.

.

.

.

.

.

.

.

.

Lithuania

9

0.3

9

0.3

7

0.2

17

0.6

Y

C

7

6

0.2

0.2

Luxembourg

2

0.4

2

0.4

1

0.2

1

0.2

Y

C

1

1

0.2

0.2

Malta

11

2.7

11

2.7

15

3.6

6

1.4

Y

C

22

22

5.2

4.9

Netherlands

571

13.8

622

14.9

635

15.2

652

15.5

25%

C

550

546

13.0

12.4

Norway

748

15.4

729

14.8

626

12.6

620

12.3

Y

C

569

569

11.1

11.3

Poland

333

0.9

351

0.9

441

1.2

540

1.4

Y

C

705

705

1.9

1.9

Portugal

.

.

.

.

.

.

.

.

.

.

.

.

.

.

Romania

80

0.4

90

0.4

79

0.4

92

0.5

Y

C

62

62

0.3

0.3

Slovakia

18

0.3

57

1.1

49

0.9

84

1.6

Y

C

78

78

1.4

1.5

Slovenia

224

10.9

255

12.4

245

11.9

278

13.5

Y

C

276

276

13.4

12.8

Spain

2212

5.9

2220

5.9

2260

6.0

2026

5.4

80%

C

1856

1856

5.0

4.7

Sweden

1456

15.6

1361

14.5

1387

14.6

1316

13.8

Y

C

1159

1159

12.0

11.0

United Kingdom

5616

9.0

4631

7.3

5208

8.2

5045

7.9

Y

C

4157

4157

6.5

6.3

EU/EEA

22071

6.0

20828

5.7

20876

5.7

20014

5.4

.

C

17533

17528

4.8

4.6

Slide2

Figure 1. Reported, confirmed cases of invasive pneumococcal disease, EU/EEA, 2014

Source: Country reports from Austria, Belgium, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom.Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive pneumococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Slide3

Figure 2. Number of reported, confirmed cases of invasive pneumococcal disease per 100 000 population, EU/EEA, 2014

Source: Country reports from: Austria, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive pneumococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Slide4

Figure 3. Cases of reported, confirmed invasive pneumococcal disease, by age and gender, EU/EEA, 2014

Source: Country reports from: Austria, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive pneumococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Slide5

Figure 4. Seasonal distribution of reported, confirmed cases of invasive pneumococcal disease, EU/EEA, 2014 compared with 2010−2013

Source: Country reports from: Austria, Belgium, Cyprus, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom.Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive pneumococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Slide6

Figure 5. Trend and number of reported, confirmed cases of invasive pneumococcal disease, EU/EEA, 2010−2014

Source: Country reports from Austria, Belgium, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom.Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive pneumococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Slide7

Figure 6. Distribution of confirmed cases of invasive pneumococcal disease: most common serotypes in 2014 (n=12 980), 2013 (n=14 811) and 2012 (n=14 845)

* Covered by PCV7, PCV10, PCV13 and PPV23~ Covered by PCV10, PCV13 and PPV23† Covered by PCV13 and PPV23˄ Covered by PPV23Source: Country reports from: Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Romania, Slovakia, Slovenia, Spain, Sweden, United Kingdom.Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive pneumococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Slide8

Figure 7. Invasive pneumococcal disease, reported confirmed cases aged <5 years: serotype distribution by PCV vaccine type, 2011–2014 (n= 4 783)

* Although serotype 6A is included in PCV13 and not in PCV7, it is considered to be a PCV7 serotype in the analysis due to documented cross-protection provided by the serotype 6B antigen in PCV7. PCV7 serotypes: 4, 6A, 6B, 9V, 14, 18C, 19F, 23F; PCV10non7 serotypes: 1, 5, 7F; PCV13non10 serotypes: 3, 19A; Non-PCV serotypes: all remaining serotypes.Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive pneumococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Slide9

Figure 8. Susceptibility of confirmed cases of invasive pneumococcal disease to cefotaxime/ceftriaxone, penicillin and erythromycin, 2012–2014

Source: For penicillin, country reports from: Austria, Belgium, Cyprus (2012), Denmark, Estonia, Finland, France, Hungary, Iceland (2012, 2014), Ireland, Italy, Latvia (2013, 2014), Lithuania (2012, 2013), Norway, Poland, Romania (2013), Slovakia, Slovenia, Spain, United Kingdom (2012, 2013, 2014). Total number of cases – 2012: n=12 226; 2013: n=11 493; 2014: n=9 283.For erythromycin, country reports from: Austria, Cyprus (2013, 2014), Denmark, Estonia, Finland, France, Hungary, Iceland (2012, 2014), Ireland, Italy, Latvia (2013, 2014), Lithuania (2012, 2013), Norway, Poland, Romania (2013), Slovakia, Slovenia, Spain, United Kingdom (2012, 2013, 2014). Total number of cases – 2012: n=9 685; 2013: n=9 202; 2014: n=7 548.For cefotaxime/ceftriaxone, country reports from: Austria (2012, 2013), Cyprus (2012), Denmark, Estonia, Finland (2012, 2014), France (2012), Hungary, Iceland (2012, 2014), Ireland, Latvia (2013, 2014), Lithuania (2012, 2013), Norway, Poland, Romania (2013), Slovakia, Slovenia, Spain, United Kingdom (2012, 2013, 2014). Total number of cases – 2012: n=6 419; 2013: n=4 715; 2014: n=4 592.Note: SIR values (susceptible, intermediate, and resistant) are displayed as interpreted by the reporting countries. ‘Intermediate’ and ‘resistant’ were categorised as ‘non-susceptible’. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2015. Invasive pneumococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

Slide10

Table. Invasive pneumococcal disease, surveillance systems overview, 2014

Surveillance characteristics: compulsory (Cp), comprehensive (co), voluntary (V), other (O), active (A), passive (P), case-based (C), aggregated (A)Data reported by: laboratories (L), physicians (P), hospitals (H), other (O)Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2016. Invasive pneumococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, 2016. Reproduction is authorised, provided the source is acknowledged

 

Surveillance

Data reported by

Case definition used

characteristics

Country

Data source

 

L

P

H

O

 

Austria

AT-Epidemiegesetz

Cp

Co

P

C

Y

Y

Y

Y

EU-2008

Belgium

BE-REFLAB

V

Se

A

C

Y

N

N

N

EU-2008

Bulgaria

BG-NATIONAL_SURVEILLANCE

Cp

Co

P

A

Y

Y

Y

Y

EU-2008

Croatia

HR-CNIPH

Cp

Co

P

A

Y

Y

Y

Y

EU-2012

Cyprus

CY-NOTIFIED_DISEASES

Cp

Co

P

C

N

Y

N

N

EU-2008

Czech Republic

CZ-NRL-STR

Cp

Co

A

C

Y

Y

Y

N

EU-2008

Denmark

DK-LAB

Cp

Co

P

C

Y

N

N

N

Not specified/unknown

Estonia

EE-NAKIS

Cp

Co

P

C

Y

Y

Y

N

EU-2012

Finland

FI-NIDR

Cp

Co

P

C

Y

N

N

N

Not specified/unknown

France

FR-EPIBAC

V

Se

A

C

Y

N

Y

N

EU-2008

Greece

EL-Notification/Laboratory data

Cp

Co

P

C

Y

Y

Y

Y

EU-2008

Hungary

HU-NRL_PNEU

V

Co

P

C

Y

N

N

N

EU-2008

Iceland

IS-SUBJECT_TO_REGISTRATION

Cp

Co

P

C

Y

Y

Y

N

EU-2012

Ireland

IE-PNEU

Cp

Co

P

C

Y

Y

Y

N

EU-2008

Italy

IT-MENINGITIS

V

Co

P

C

N

Y

Y

N

EU-2012

Latvia

LV-BSN

Cp

Co

P

C

Y

Y

Y

Y

EU-2012

Lithuania

LT-COMMUNICABLE_DISEASES

Cp

Co

P

C

Y

Y

N

N

EU-2008

Luxembourg

LU-SYSTEM1

Cp

Co

P

C

N

Y

N

N

EU-2002

Malta

MT-DISEASE_SURVEILLANCE

Cp

Co

P

C

Y

Y

Y

Y

EU-2008

Netherlands

NL-NRBM

V

Se

P

C

Y

N

N

N

EU-2008

Norway

NO-MSIS_A

Cp

Co

P

C

Y

Y

Y

N

EU-2012

Poland

PL-NATIONAL_SURVEILLANCE

Cp

Co

P

C

Y

Y

Y

N

EU-2008

Romania

RO-RNSSy

Cp

Co

P

C

N

N

Y

N

EU-2008

Slovakia

SK-EPIS

Cp

Co

A

C

Y

Y

Y

N

EU-2012

Slovenia

SI-SURVIVAL

Cp

Co

P

C

Y

Y

Y

N

EU-2008

Spain

ES-NRL

V

O

P

C

Y

N

Y

N

Not specified/unknown

Sweden

SE-SMINET

Cp

Co

P

C

Y

Y

Y

N

EU-2012

United Kingdom

UK-PNEUMOCOCCAL

O

Co

P

C

Y

N

Y

Y

EU-2012